MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
36.35
-2.72 (-6.96%)
Apr 1, 2025, 4:00 PM EDT - Market closed

MLTX Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for MLTX stock have an average target of 80.5, with a low estimate of 66 and a high estimate of 104. The average target predicts an increase of 121.46% from the current stock price of 36.35.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $66 $80.5 $73 $104
Change +81.57% +121.46% +100.83% +186.11%

Analyst Ratings

The average analyst rating for MLTX stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Nov '24Dec '24Jan '25Feb '25Mar '25Apr '25
Strong Buy 553333
Buy 333344
Hold 221111
Sell 000000
Strong Sell 000000
Total 10107788

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
RBC Capital
RBC Capital
Buy
Initiates
$67
Buy Initiates $67 +84.32% Mar 18, 2025
Goldman Sachs
Goldman Sachs
Strong Buy
Maintains
$82$73
Strong Buy Maintains $82$73 +100.83% Feb 27, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$100
Strong Buy Reiterates $100 +175.10% Feb 27, 2025
Needham
Needham
Strong Buy
Maintains
$62$66
Strong Buy Maintains $62$66 +81.57% Feb 27, 2025
Goldman Sachs
Goldman Sachs
Strong Buy
Upgrades
$62$82
Strong Buy Upgrades $62$82 +125.58% Jan 17, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
1.13B
from 553.54M
Increased by 103.42%
Revenue Next Year
n/a
from 1.13B
EPS This Year
-3.11
from -1.89
EPS Next Year
-3.77
from -3.11
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027 FY 2028 FY 2029
Period Ending Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027 Dec 31, 2028 Dec 31, 2029
Revenue
--101.08M553.54M1.13B
Revenue Growth
---447.63%103.42%---
EPS
-8.21-1.70-0.73-1.89-3.11-3.77-3.87-0.61
EPS Growth
--------
Forward PE
--------
No. Analysts ----1614126
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High n/a n/a 192.1M
Avg n/a n/a 101.1M
Low n/a n/a 45.0M

Revenue Growth

Revenue Growth 20252026202720282029
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 20252026202720282029
High -2.36 -2.72 -2.78
Avg -3.11 -3.77 -3.87
Low -3.26 -4.93 -4.88

EPS Growth

EPS Growth 20252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.